Author： Giembycz Mark A
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.7, 2001-07, pp. : 1361-1379
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Torphy T.J. Barnette M.S. Underwood D.C. Griswold D.E. Christensen S.B. Murdoch R.D. Nieman R.B. Compton C.H.
Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. :
Access to resources
Recommend
Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. :
PDE4 inhibitors and chronic obstructive pulmonary disease
By Wolda S.L.
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. :
By Louie Samuel Zeki Amir A Schivo Michael Chan Andrew L Yoneda Ken Y Avdalovic Mark Morrissey Brian M Albertson Timothy E
Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. :